Target-directed cancer: protein-ligand interactions
Drug Target Review
NOVEMBER 1, 2023
So that is a wide range of techniques to look at the protein-ligand interactions, all with the aim to guide the optimisation of our first screening hits to potent inhibitors that hopefully are cell-active at some point. 2011) D67, 386-394) using PDB ID 4GV1 which was published as part of Addie et al. Acta Cryst.
96 
Let's personalize your content